Should Merck license the compound? Merck would be responsible for 1) the approval of Davanrik 2) the manufacture of Danavrik 3) marketing of Danavrik Merck would pay LAB for 1) initial fee 2) royalty on all sales 3) make additional pymts as Danavrik completed each stage of approval process (3 Phases) Additional facts: approval process should take 7 years patent will cover 17 years (7 of approval process nad 10 yr period of exclusivity beginning in yr 7) 1 Assumptions: All Cash flows
Premium Decision tree Arithmetic mean Variance
Should Merck license the compound? Merck would be responsible for 1) the approval of Davanrik 2) the manufacture of Danavrik 3) marketing of Danavrik Merck would pay LAB for 1) initial fee 2) royalty on all sales 3) make additional pymts as Danavrik completed each stage of approval process (3 Phases) Additional facts: approval process should take 7 years patent will cover 17 years (7 of approval process nad 10 yr period of exclusivity beginning in yr 7) 1 Assumptions:
Premium Decision theory Probability theory Decision tree
BUAD820 – Case 2 Merck Case Decision Tree and Analysis Presented By – Sridevi Chennuri Nuray Coban Subhashini Reddy Merck & Company :Evaluating a Drug Licensing Opportunity • Background - Merck & Company : •In 2000‚ it was a global research-driven pharmaceutical company that discovers‚ develop‚ manufactures and markets a broad range of human and animal health products‚ directly and through its joint ventures‚ and provides pharmaceutical benefit management services through Merck-Medco Managed Care
Premium Clinical trial Decision tree Expected value
Opportunities for Traditional “Drug” Companies Raymond J. Grote‚ III June 5‚ 2013 Boston University MET AD 741 Abstract: This paper explores two large‚ influential companies‚ Eli Lilly and Pfizer. Despite their unquestionable success and knowledge of the market for diabetes products‚ they failed badly in crucial decisions. This paper proposes reasons that the companies failed in certain efforts and recommendations for changes and future growth opportunities. What went wrong? From
Premium Insulin Marketing
The strategy of the company and the problems the company faced in 2003 As the case stated‚ there existed a lot of problems in Distillers Delight in the United Kingdom in 2003. In addition‚ the strategy the company adopted affects the performance of the brand significantly. The strategy that the company adopted may be the market niche. Market niche is a strategy adopted when there is a small market segment for which the products are specially designed. (Appendix A) As the case demonstrates‚ the brand
Premium Brand Marketing Vermiform appendix
Starbucks Harvard Business School Starbucks: Delivering Customer Service MKT 690: Marketing Management Mike DiPietro Spring 2015 Nevin Johnson Abstract The following diction is an analysis of the Harvard Business School study on Starbucks coffee‚ titled “Starbucks: Delivering Customer Service.” There are many factors accounted for Starbucks extraordinary success in the 1990s. Though Starbucks offered great coffee and a great experience their customer satisfaction scores declined. There are many
Premium Coffee Starbucks
Cipla 2011‚ Harvard Business Case‚ March 27‚ 2012 1°) Since AIDS was identified in 1982‚ various entities have been aiming at limiting the expansion of the pandemic. However each of these entities has had a different role and thus different results: * The World Health Organization has had a critical role through the coordination of the different actors involved. It has obtained significant results in terms of treatments coverage in the last few years. Its action has been completed by the UNAIDS
Premium Patent Developed country AIDS
WorldCom Critical Thinking Case Study Not only did WorldCom’s organizational culture contributed to the accounting breaches‚ in my opinion it was the catalyst to its ultimate demise in July 2002. Richard Thornburgh stated that “WorldCom could not have failed as a result of the actions of a limited number of individuals. Rather‚ there was a broad breakdown of the system of internal controls‚ corporate governance and individual responsibility‚ all of which worked together to create a culture in
Premium Ethics Corporate governance Fraud
Pharmaceuticals: Merck Sustaining Long-term Advantage Through Information Technology Hiroshi Amari Working Paper No. 161 Working Paper Series Center on Japanese Economy and Business Columbia Business School December 1998 Columbia-Yale Project: Use of Software to Achieve Competitive Advantage PHARMACEUTICALS: MERCK Sustaining Long-term Advantage Through Information Technology Prepared by Hiroshi Amari Research Associate‚ Yale University William V. Rapp and Hugh T. Patrick Co-principal
Premium Clinical trial Pharmaceutical industry Drug development
The actions Merck undertook when marketing Vioxx and emphasizing its safety even after finding out the product’s side effects endangered all its key stakeholders and showed the real face of the company that accented its highly ethical maxims. Cardiovascular side effects of the Vioxx increased the risk of complications that could have caused patient’s death‚ therefore Merck violated the basic right to life of all the Vioxx consumers. It was already mentioned that Vioxx caused 3468 deaths by heart
Premium Enron Business ethics Ethics